FDA Drug Application (202301) for EFAVIRENZ by MICRO LABS LTD

Back to FDA Applications sponsored by MICRO LABS LTD

Application Number202301
Product Number001
FormTABLET; ORAL
Dosage600MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEFAVIRENZ
Active IngredientEFAVIRENZ

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11


Back to FDA Applications sponsored by MICRO LABS LTD